6-42704564-G-C
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000322.5(PRPH2):c.629C>G(p.Pro210Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P210L) has been classified as Pathogenic.
Frequency
Consequence
NM_000322.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461892Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727246
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not provided Pathogenic:2Other:1
Curator: Global Variome, with Curator vacancy. Submitters to LOVD: Julia Lopez, Manon Peeters. -
In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 7519821, 17504850, 11139241, 25082885, 16885924, 21071739, 16799052, 22863181, 7862413, 32531846) -
- -
PRPH2-related disorder Pathogenic:2
The PRPH2 c.629C>G (p.Pro210Arg) variant is a missense variant that has been reported in four studies, where it was found in a total of six individuals with PRPH2-related disorders, including one homozygote and five heterozygotes (Feist et al. 1994; Gorin et al. 1995; Zhuk et al. 2006; Duncan et al. 2011). The family of one individual reported by Gorin et al. (1995) included at least 10 affected and three unaffected individuals who carried the variant, demonstrating unclear segregation. The p.Pro210Arg variant was absent from 127 controls in the above studies, and it is not reported in the 1000 Genomes Project, the Exome Sequencing Project, or the Exome Aggregation Consortium despite being located in a region of good sequencing coverage. Therefore, the variant is presumed to be rare. Based on the evidence, the p.Pro210Arg variant is classified as likely pathogenic for PRPH2-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -
This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 210 of the PRPH2 protein (p.Pro210Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant retinal disease (PMID: 7862413, 11139241, 17504850). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 13173). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt PRPH2 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
Vitelliform macular dystrophy 3 Pathogenic:1
- -
Patterned dystrophy of the retinal pigment epithelium Pathogenic:1
The variant NM_000322.4:c.629C>G in the PRPH2 gene has been previously studied(PMIDs 7519821, 25082885). We found this variant in 7 patient(s) in a PRPH2 cohort study (Reeves et al. 2020). This variant is listed in dbSNP and/or HGMD (rs61755798,CM941210). It is absent in gnomAD browser. It is enriched in the PRPH2 disease cohort. We invoked ACMG criteria [PS4, PP1-S, PM1, PM2, PM5, PP3, PP5] and classified NM_000322.4:c.629C>G in the PRPH2 gene as a Pathogenic mutation. -
Vitelliform macular dystrophy 2 Pathogenic:1
The variant NM_000322.4:c.629C>G in the PRPH2 gene has been previously studied(PMIDs 7519821, 25082885). We found this variant in 7 patient(s) in a PRPH2 cohort study (Reeves et al. 2020). This variant is listed in dbSNP and/or HGMD (rs61755798,CM941210). It is absent in gnomAD browser. It is enriched in the PRPH2 disease cohort. We invoked ACMG criteria [PS4, PP1-S, PM1, PM2, PM5, PP3, PP5] and classified NM_000322.4:c.629C>G in the PRPH2 gene as a Pathogenic mutation. -
Retinal dystrophy Pathogenic:1
- -
Stargardt disease Pathogenic:1
The variant NM_000322.4:c.629C>G in the PRPH2 gene has been previously studied(PMIDs 7519821, 25082885). We found this variant in 7 patient(s) in a PRPH2 cohort study (Reeves et al. 2020). This variant is listed in dbSNP and/or HGMD (rs61755798,CM941210). It is absent in gnomAD browser. It is enriched in the PRPH2 disease cohort. We invoked ACMG criteria [PS4, PP1-S, PM1, PM2, PM5, PP3, PP5] and classified NM_000322.4:c.629C>G in the PRPH2 gene as a Pathogenic mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at